A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Clinical trial NCT04776629 · COMPLETED

Trial details

NCT number: NCT04776629
Sponsor: Abcentra
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Inflammation Coronary Artery Disease Cardiometabolic Syndrome

Start date: 2021-06-30
Primary completion: 2022-11-11
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.